These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35920077)

  • 1. National Survey of United Kingdom Paediatric Allergy Services.
    Wells R; McKay C; Makwana N; Vyas D; Vaughan S; Christopher A; Thomas L; Primett M; Diwakar L; Alvis S; Perkin MR
    Clin Exp Allergy; 2022 Nov; 52(11):1276-1290. PubMed ID: 35920077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of COVID-19 Pandemic on Adult and Pediatric Allergy & Immunology Services in the UK National Health Service.
    Krishna MT; Beck S; Gribbin N; Nasser S; Turner PJ; Hambleton S; Sargur R; Whyte A; Bethune C
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):709-722.e2. PubMed ID: 33271350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UK NEQAS survey of allergen component testing across the United Kingdom and other European countries.
    Saleem R; Keymer C; Patel D; Egner W; Rowbottom AW
    Clin Exp Immunol; 2017 Jun; 188(3):387-393. PubMed ID: 28423454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of clinical allergy services provided by clinical immunologists in the UK.
    El-Shanawany TM; Arnold H; Carne E; Misbah SA; Egner W; Wallington TB; Herriot R; Williams PE
    J Clin Pathol; 2005 Dec; 58(12):1283-90. PubMed ID: 16311348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An epidemiological survey of hymenoptera venom allergy in the Spanish paediatric population.
    Martínez-Cañavate A; Tabar AI; Eseverri JL; Martín F; Pedemonte-Marco C
    Allergol Immunopathol (Madr); 2010; 38(5):259-62. PubMed ID: 20580150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A UK national survey of investigations for beta-lactam hypersensitivity - heterogeneity in practice and a need for national guidelines - on behalf of British Society for Allergy and Clinical Immunology (BSACI).
    Richter AG; Nasser SM; Krishna MT
    Clin Exp Allergy; 2013 Aug; 43(8):941-9. PubMed ID: 23889247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How many paediatric referrals to an allergist could be managed by a general practitioner with special interest?
    Isinkaye T; Gilbert S; Seddon P; Fox AT; Leech S; Pollock I; Smith H
    Pediatr Allergy Immunol; 2016 Mar; 27(2):195-200. PubMed ID: 26572923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for the use of allergen immunotherapy. Canadian Society of Allergy and Clinical Immunology.
    CMAJ; 1995 May; 152(9):1413-9. PubMed ID: 7728690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oral food desensitization in the Italian allergy centres.
    Meglio P; Caminiti L; Pajno GB; Dello Iacono I; Tripodi S; Verga MC; Martelli A;
    Eur Ann Allergy Clin Immunol; 2015 May; 47(3):68-76. PubMed ID: 25951144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term management of cases of venom-induced anaphylaxis is suboptimal.
    Tritt A; Gabrielli S; Zahabi S; Clarke A; Moisan J; Eisman H; Morris J; Restivo L; Shand G; Ben-Shoshan M
    Ann Allergy Asthma Immunol; 2018 Aug; 121(2):229-234.e1. PubMed ID: 29656144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity and threshold of peanut reactivity during hospital-based open oral food challenges: An international multicenter survey.
    Arkwright PD; MacMahon J; Koplin J; Rajput S; Cross S; Fitzsimons R; Davidson N; Deshpande V; Rao N; Lumsden C; Lacy D; Allen KJ; Vance G; Mwenechanya J; Fox AT; Erlewyn-Lajeunesse M; Mistry H; Hourihane JO
    Pediatr Allergy Immunol; 2018 Nov; 29(7):754-761. PubMed ID: 30022517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A national audit of pollen immunotherapy for children in the United Kingdom: patient selection and programme safety.
    Vance GH; Goldring S; Warner JO; Cox H; Sihra B; Hughes S; Gardner J; North J; Roberts G; Proudfoot CA; Clarke A; Luyt DK; Gillies D; Fox AT
    Clin Exp Allergy; 2011 Sep; 41(9):1313-23. PubMed ID: 21762222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Walnut oral immunotherapy for desensitisation of walnut and additional tree nut allergies (Nut CRACKER): a single-centre, prospective cohort study.
    Elizur A; Appel MY; Nachshon L; Levy MB; Epstein-Rigbi N; Pontoppidan B; Lidholm J; Goldberg MR
    Lancet Child Adolesc Health; 2019 May; 3(5):312-321. PubMed ID: 30926371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen Immunotherapy Extract Shortages and Their Effects on Clinical Care: A Work Group Report of the AAAAI Immunotherapy, Allergen Standardization, and Allergy Diagnostics Committee.
    Ezhuthachan ID; Banks TA; Cerise JE; Wong SC; Ponda P
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):444-452. PubMed ID: 34840110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of a General Practitioner-led community paediatric allergy clinic: A service evaluation.
    El-Shanawany IR; Wade C; Holloway JA
    Clin Exp Allergy; 2019 May; 49(5):690-700. PubMed ID: 30791174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specialist perioperative allergy clinic services in the UK 2016: Results from the Royal College of Anaesthetists Sixth National Audit Project.
    Egner W; Cook T; Harper N; Garcez T; Marinho S; Kong KL; Nasser S; Thomas M; Warner A; Hitchman J; Floss K;
    Clin Exp Allergy; 2017 Oct; 47(10):1318-1330. PubMed ID: 28787764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
    O'B Hourihane J; Beyer K; Abbas A; Fernández-Rivas M; Turner PJ; Blumchen K; Nilsson C; Ibáñez MD; Deschildre A; Muraro A; Sharma V; Erlewyn-Lajeunesse M; Zubeldia JM; De Blay F; Sauvage CD; Byrne A; Chapman J; Boralevi F; DunnGalvin A; O'Neill C; Norval D; Vereda A; Skeel B; Adelman DC; du Toit G
    Lancet Child Adolesc Health; 2020 Oct; 4(10):728-739. PubMed ID: 32702315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice of venom immunotherapy in the United Kingdom: a national audit and review of literature.
    Diwakar L; Noorani S; Huissoon AP; Frew AJ; Krishna MT
    Clin Exp Allergy; 2008 Oct; 38(10):1651-8. PubMed ID: 18727621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy.
    Fernandez-Rivas M; Vereda A; Vickery BP; Sharma V; Nilsson C; Muraro A; Hourihane JO; DunnGalvin A; du Toit G; Blumchen K; Beyer K; Smith A; Ryan R; Adelman DC; Jones SM
    Allergy; 2022 Mar; 77(3):991-1003. PubMed ID: 34320250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study).
    Chebar Lozinsky A; Loke P; Orsini F; O'Sullivan M; L Prescott S; Gold MS; Quinn P; DunnGalvin A; Lk Tang M;
    BMJ Open; 2020 Sep; 10(9):e035871. PubMed ID: 32912942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.